SCHEMBL7948372

SCHEMBL7948372

Cc1c([N+](=O)[O-])cc2[nH]c(=O)c(=O)[nH]c2c1CN(C)C(=O)c1ccc(Cl)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIA1 P42261 3/20 0.51
GRIA2 P42262 3/20 0.51
GRIA3 P42263 3/20 0.51
GRIA4 P48058 3/20 0.51
GRIN2D O15399 9/20 0.41
GRIN3B O60391 9/20 0.41
GRIN1 Q05586 9/20 0.41
GRIN2A Q12879 9/20 0.41
GRIN2B Q13224 9/20 0.41
GRIN2C Q14957 9/20 0.41
GRIN3A Q8TCU5 9/20 0.41
KMT2A Q03164 3/20 0.39
ATM Q13315 1/20 0.39
MEN1 O00255 1/20 0.38
ALDH1A1 P00352 2/20 0.38
POLB P06746 1/20 0.37
LMNA P02545 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
MAPT P10636 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7948364 0.91 GRIA1 (0.49) GRIA1GRIA2GRIA3GRIA4GRIN2D
SCHEMBL7957898 0.90 GRIA1 (0.49) GRIA1GRIA2GRIA3GRIA4GRIN2D
SCHEMBL7959292 0.90 GRIA1 (0.53) GRIA1GRIA2GRIA3GRIA4GRIN2D
SCHEMBL7948349 0.88 GRIA1 (0.48) GRIA1GRIA2GRIA3GRIA4GRIN2D
SCHEMBL7948140 0.87 GRIA1 (0.48) GRIA1GRIA2GRIA3GRIA4GRIN2D
SCHEMBL7958054 0.84 GRIA1 (0.56) GRIA1GRIA2GRIA3GRIA4GRIN2D
SCHEMBL8894957 0.83 GRIA1 (0.48) GRIA1GRIA2GRIA3GRIA4GRIN2D
SCHEMBL7948153 0.81 GRIA1 (0.61) GRIA1GRIA2GRIA3GRIA4GRIN2D
SCHEMBL7959733 0.81 ALDH1A1 (0.53) GRIA1GRIA2GRIA3GRIA4GRIN2D
SCHEMBL7959487 0.80 GRIA1 (0.47) GRIA1GRIA2GRIA3GRIA4GRIN2D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6191134-B1 STROKE THERAPY, ANTIISCHEMIC AGENTS, BRAIN DISORDERS WARNER-LAMBERT COMPANY 2001-02-20 US claimed
US-6268366-B1 Amide derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists WARNER-LAMBERT COMPANY 2001-07-31 US disclosed
US-6191134-B1 STROKE THERAPY, ANTIISCHEMIC AGENTS, BRAIN DISORDERS WARNER-LAMBERT COMPANY 2001-02-20 US disclosed
WO-1997046539-A1 AMIDE DERIVATIVES OF SUBSTITUTED QUINOXALINE 2,3-DIONES AS GLUTAMATE RECEPTOR ANTAGONISTS WARNER-LAMBERT COMPANY (US) 1997-12-11 WO disclosed